The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
Subscribe
0 Comments
Oldest